These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Neoadjuvant chemotherapy or chemoradiotherapy for locally advanced esophageal cancer. Smithers BM; Thomson I Thorac Surg Clin; 2013 Nov; 23(4):509-23. PubMed ID: 24199701 [TBL] [Abstract][Full Text] [Related]
23. Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer. Lim SH; Hong M; Ahn S; Choi YL; Kim KM; Oh D; Ahn YC; Jung SH; Ahn MJ; Park K; Zo JI; Shim YM; Sun JM Eur J Cancer; 2016 Jan; 52():1-9. PubMed ID: 26623522 [TBL] [Abstract][Full Text] [Related]
24. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study. Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152 [TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience. Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725 [TBL] [Abstract][Full Text] [Related]
26. TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients. Piro G; Giacopuzzi S; Bencivenga M; Carbone C; Verlato G; Frizziero M; Zanotto M; Mina MM; Merz V; Santoro R; Zanoni A; De Manzoni G; Tortora G; Melisi D Br J Cancer; 2015 Sep; 113(6):878-85. PubMed ID: 26291056 [TBL] [Abstract][Full Text] [Related]
27. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma. Li SH; Huang EY; Lu HI; Huang WT; Yen CC; Huang WC; Chen CH J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1352-9, 1359.e1. PubMed ID: 22841170 [TBL] [Abstract][Full Text] [Related]
28. Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancer. Shaikh T; Thomay A; Ruth K; Cohen SJ; Meyer JE J Surg Oncol; 2015 Nov; 112(6):629-33. PubMed ID: 26430952 [TBL] [Abstract][Full Text] [Related]
29. Molecular Markers for the Prediction of Minor Response to Neoadjuvant Chemoradiation in Esophageal Cancer: Results of the Prospective Cologne Esophageal Response Prediction (CERP) Study. Bollschweiler E; Hölscher AH; Herbold T; Metzger R; Alakus H; Schmidt H; Drebber U; Warnecke-Eberz U Ann Surg; 2016 Nov; 264(5):839-846. PubMed ID: 27741011 [TBL] [Abstract][Full Text] [Related]